Pal, P., Mallick, S., Mandal, S.K., Das, M., Dutta, A.K., Datta, P.K., Bhadra, R., et al. (2002) A Human Placental Extract: In Vivo and in Vitro Assessments of Its Melanocyte Growth and Pigment-Inducing Activities. International Journal of Dermatology, 41, 760-767.
https://doi.org/10.1046/j.1365-4362.2002.01524.x

has been cited by the following article:

• TITLE: Case Report: Improvement of Long Lasting Hyperpigmentation by Aqueous Human Placenta Extract (Reju Growth Factor, RGF®) Treatment

  AUTHORS: Ruchee Phonchai, Bunchob Ubonsaen, Supaluk Brameld, Pimjai Naigovit

  KEYWORDS: Hyperpigmentation, Human Placenta Extract, Mesotherapy

  JOURNAL NAME: Journal of Cosmetics, Dermatological Sciences and Applications, Vol.9 No.2, May 31, 2019

  ABSTRACT: Hyperpigmentation is a common skin problem in a woman. Prolonging topical use of skin whitening may cause hyperpigmentation such as ochronosis whose condition is a challenge for treatment. An aqueous human placenta extract (RGF®) contains bioactive therapeutic molecules. There is evidence of human placenta extract showing that melanin synthesis is inhibited by placenta extract in melanocytes. We first reported the case of the hyperpigmentation improvement following face skin mesotherapy human placenta extract treatment.